1921
Volume 93, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

A population-based hepatitis survey was carried out to estimate the prevalence of hepatitis B virus (HBV) infection and its predictive factors for the state capitals from the north, south, and southeast regions of Brazil. A multistage cluster sampling was used to select, successively, census tracts, blocks, households, and residents in the age group 10–69 years in each state capital. The prevalence of hepatitis B surface antigen (HBsAg) was lower than 1% in the north, southeast, and south regions. Socioeconomic condition was associated with HBV infection in north and south regions. Variables related to the blood route transmission were associated with HBV infection only in the south whereas those related to sexual behavior were associated with HBV infection in the north and south regions. Drug use was associated in all regions, but the type of drug differed. The findings presented herein highlight the diversity of the potential transmission routes for hepatitis B transmission in Brazil. In one hand, it reinforces the importance of national control strategies of large impact already in course (immunization of infants, adolescents, and adults up to 49 years of age and blood supply screening). On the other hand, it shows that there is still room for further control measures targeted to different groups within each region.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0216
2015-12-09
2017-11-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/6/1341.html?itemId=/content/journals/10.4269/ajtmh.15-0216&mimeType=html&fmt=ahah

References

  1. WHO Media Centre. Hepatitis B. Fact Sheet No. 204. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/index.html. Accessed November 3, 2014.
  2. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS, , 2005. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34: 13291339.[Crossref]
  3. Ministério da Saúde, 2003. 30 anos do PNI/DEVEP/SVS. Brasília, Brazil: Ministério da Saúde.
  4. Luna EJA, Veras MASM, Flannery B, Moraes JC, , 2009. Household survey of hepatitis B vaccine coverage among Brazilian children. Vaccine 27: 53265331.[Crossref]
  5. Souto FJD, , 1999. Distribuição da Hepatite B no Brasil: atualização do mapa epidemiológico e proposições para seu controle. GED 18: 143150.
  6. Pereira LMMB, Martelli CMT, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima M, Cardoso MR, Turchi MD, Costa MA, de Alencar LC, Moreira RC, Figueiredo GM, Xiemens RA, Hepatitis Study Group, , 2009. Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 81: 240247.
  7. Ximenes RAA, Pereira LMB, Martelli CMT, Merchan-Humann E, Stein AT, Figueiredo GM, Braga MC, Montarroyos UR, Brasil LM, Turchi MD, da Fonseca JC, de Lima MLC, de Alencar LCA, Costa M, Coral G, Moreira RC, Cardoso MRA, , 2010. Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cad Saude Publica 26: 16931704.[Crossref]
  8. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS, , 1999. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 89: 1418.[Crossref]
  9. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS, , 2001. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135: 796800.[Crossref]
  10. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS, for the Taiwan Childhood Hepatoma Study Group, , 1997. Universal hepatitis B vaccination in Taiwan and incidence of hepatocellular carcinoma in children. N Engl J Med 336: 18551859.[Crossref]
  11. Xia G-L, Liu C-B, Cao H-L, Bi S-L, Zhan M-Y, Su C-A, Nan J-H, Qi X-Q, , 1996. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun 5: 6273.[Crossref]
  12. Liang JH, Wang M, Liu JH, Cai YS, Xu JX, , 2010. Study on the immunization coverage and effects of hepatitis B vaccine in the 20–59 years-old population in Guangzhou city [in Portuguese]. Zhonghua Liu Xing Bing Xue Za Zhi 31: 13361339.
  13. Al-Faleh FZ, Al-Jeffri M, Ramia S, Al-Rashed R, Arif M, Rezeig M, Al-Toraif I, Bakhsh M, Mishkkhas A, Makki O, Al-Freihi H, Mirdad S, AlJuma A, Yasin T, Al-Swailem A, Ayoola A, , 1999. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect 38: 167170.[Crossref]
  14. Wasley A, Kruszon-Moran D, Kuhnert W, Simard Ep, Finalli L, McQuillan G, Bell B, , 2010. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 202: 192201.[Crossref]
  15. Wu HX, Andnov A, Giulivi A, Goedhuis NJ, Baptiste B, Furseth J, Poliquin D, Chan JIP, Bolesnikov G, Moffat B, Paton S, Wu J, , 2005. Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999–2003. Int J Med Sci 2: 143146.[Crossref]
  16. Braga WS, Castilho MC, Borges FG, Martinho AC, Rodrigues IS, Azevedo EP, Scazufca M, Menezes PR, , 2012. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the western Brazilian Amazon. Rev Soc Bras Med Trop 45: 1317.[Crossref]
  17. Paim J, Travassos C, Almeida C, Bahia L, Macinko J, , 2011. The Brazilian health system: history, advances, and challenges. Lancet 177: 17781791.[Crossref]
  18. Ott JJ, Stevens GA, Groeger J, Wiersma ST, , 2012. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsaG seroprevalence and endemicity. Vaccine 30: 22122219.[Crossref]
  19. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP, , 2006. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28: 112125.[Crossref]
  20. Wasley A, Miller JT, Finelli L, , 2007. Surveillance for acute viral hepatitis: United States, 2005. MMWR Surveill Summ 56: 124.
  21. Souto FJ, Fontes CJ, Oliveira JM, Gaspar AM, Lyra LG, , 1997. Epidemiological survey of infection with hepatitis B virus in the savannah and wetlands (Pantanal) of central Brazil. Ann Trop Med Parasitol 91: 411416.[Crossref]
  22. Silveira TR, da Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, Urdeneta E, Clemens SAC, , 1999. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica 6: 378383.[Crossref]
  23. El Khouri M, Duarte LS, Ribeiro RB, da Silva LFF, Camargo LMA, dos Santos VA, Burattini MN, Corbett CEP, , 2005. Seroprevalence of hepatitis B virus and hepatitis C virus in Monte Negro in the Brazilian western Amazon region. Clinics 60: 2936.[Crossref]
  24. Diel R, Helle J, Gottschalk R, , 2005. Transmission of hepatitis B in Hamburg, Germany, 1998–2002: a prospective, population-based study. Med Microbiol Immunol (Berl) 194: 193199.[Crossref]
  25. Oliveira MLA, Bastos FI, Telles PR, Yoshida CFT, Schatzmayr HG, Paetzold U, Pauli G, Schreier E, , 1999. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Braz J Med Biol Res 32: 11071114.
  26. de Souza MG, Passos ADC, Machado AA, Figueiredo JFC, Esmeraldino LE, , 2004. HIV and hepatitis B virus co-infection: prevalence and risk factors [in Portuguese]. Rev Soc Bras Med Trop 37: 391395.[Crossref]
  27. Patavino GM, Almeida-Neto C, Liu J, Wright DJ, Mendrone-Junior A, Ferreira MI, Busch MP, Sabino EC, NHLBI Retrovirus Epidemiology Study-II (REDS-II), International Component, , 2012. Number of recent sexual partners among blood donors in Brazil: associations with donor demographics, donation characteristics, and infectious disease markers. Transfusion 52: 151159.[Crossref]
  28. Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S, , 2008. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol 80: 5357.[Crossref]
  29. Miranda AE, Figueiredo NC, Schmidt R, Page-Shafer KA, , 2008. Population-based survey of the prevalence of HIV, syphilis, hepatitis B and hepatitis C infections, and associated risk factors among young women in Vitória, Brazil. AIDS Behav 12 (Suppl): S25S31.[Crossref]
  30. Pereira RARA, Mussi ADH, Azevedo VCS, Souto FJD, , 2006. Hepatitis B virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil. BMC Infect Dis 6: 34.[Crossref]
  31. Lewis-Ximenez LL, do O KM, Ginuino CF, Silva JC, Schatzmayr HG, Stuver S, Yoshida CF, , 2002. Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil. BMC Public Health 2: 26.[Crossref]
  32. Barreto ML, Teixeira MG, Bastos FI, Ximenes RAA, Barata RB, Rodrigues LC, , 2011. Successes and failures in the control of infectious diseases in Brazil: social and environment, context, policies, intervention and research need. Lancet 377: 18771889 [British edition].[Crossref]
  33. Matos MAD, Ferreira RC, Rodrigues FP, Marinho TA, Lopes CL, Novais AC, Motta-Castro AR, Teles SA, Souto FJ, Martins RM, , 2013. Occult hepatitis B virus infection among injecting drug users in the central-west region of Brazil. Mem Inst Oswaldo Cruz 108: 386389.[Crossref]
  34. Wu H, Shen B, , 2010. Health care-associated transmission of hepatitis B and C viruses in endoscopy units. Clin Liver Dis 14: 6168.[Crossref]
  35. Pereira LMMB, Martelli CMT, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso RMA, Figueiredo GM, Montarroyos UR, Braga C, Turchi MD, Coral G, Crespo D, Lima MLC, Alencar LCA, Costa M, dos Santos AA, Xiemens RAA, , 2013. Prevalence and risk factors of hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis 13: 6.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0216
Loading
/content/journals/10.4269/ajtmh.15-0216
Loading

Data & Media loading...

  • Received : 18 Mar 2015
  • Accepted : 07 Jul 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error